Taxus paclitaxel-coated stent: Feasibility study data; marketed in Europe

In the double-blind, international TAXUS II study in 536 patients, 12-month follow-up data showed that patients given a slow-release paclitaxel stent had a 10.9% MACE rate with a 4.7% TLR rate and pat...